Enoximone
CAS No. 77671-31-9
Enoximone ( —— )
Catalog No. M21990 CAS No. 77671-31-9
Enoximone is a selective inhibitor of phosphodiesterase III (PDE3), with treatment of congestive heart failure.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 82 | In Stock |
|
10MG | 120 | In Stock |
|
25MG | 237 | In Stock |
|
50MG | 426 | In Stock |
|
100MG | 624 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEnoximone
-
NoteResearch use only, not for human use.
-
Brief DescriptionEnoximone is a selective inhibitor of phosphodiesterase III (PDE3), with treatment of congestive heart failure.
-
DescriptionEnoximone is a selective inhibitor of phosphodiesterase III (PDE3), with treatment of congestive heart failure.Perioperative Enoximone administration improved renal function in patients undergoing on-pump cardiac surgery.
-
Synonyms——
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number77671-31-9
-
Formula Weight248.3
-
Molecular FormulaC12H12N2O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCSc1ccc(cc1)C(=O)c1[nH]c(=O)[nH]c1C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Emiliano Angeloni , Giovanni Melina , Francesco Federici,et al.Preliminary Results of the Multicenter Observational Study With Enoximone in Cardiac Surgery (MOSEC).Observational Study Int J Cardiol. 2018 Oct 15;269:51-55.
molnova catalog
related products
-
Udenafil
A potent and selective phosphodiesterase 5 (PDE5) inhibitor for treat erectile dysfunction.
-
LJI308
LJI308 is a potent, and pan-RSK (p90 ribosomal S6 kinase) inhibitor with IC50 of 6 nM, 4 nM, and 13 nM for RSK1, RSK2, and RSK3, respectively.
-
Filaminast
Filaminast (WAY-PDA-641;PDA-641;WAY-123641) is a potent and selective PDE4 inhibitor with IC50 of 420 nM, displays 36-fold selectivity over PDE3.